⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Jane MayrinMD

Endocrinology · Philadelphia, PA 19115

NPI: 1467679738

Share:

7

🟢 Low

Risk Flags

Elevated cost per beneficiaryHigh fills per patient

Risk indicators are statistical patterns, not allegations. Learn more

26,989

Total Claims

$8.6M

Drug Cost

1,099

Beneficiaries

$7,858

Cost/Patient

Risk Score Breakdown 7/100

Low (0)Moderate (15)Elevated (30)High (50+)
Cost per patient outlier+3
High fills per patient+3

Score components are additive. Read full methodology

Peer Comparison vs. 6,382 Endocrinology providers

+100%

Cost per patient vs peers

$7,858 vs $3,933 avg

-17%

Brand preference vs peers

42.2% vs 51.2% avg

Brand vs Generic

58% generic

Brand: 10,668 claims · $8.2M

Generic: 14,593 claims · $324K

Patient Profile

75

Avg Age

68%

Female

1.67

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data